AI assistant
Sending…
LIFECORE BIOMEDICAL, INC. \DE\ — Director's Dealing 2021
Jun 8, 2021
33431_dirs_2021-06-08_76247b57-b9f6-4dc3-b362-f614dc0e2ed3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LANDEC CORP \CA\ (LNDC)
CIK: 0001005286
Period of Report: 2021-06-04
Reporting Person: Carosella Deborah D (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-06-04 | Restricted Stock Unit | $ | A | 7059 | Acquired | Common Stock (7059) | Direct |
Footnotes
F1: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis.
F2: Restricted Stock Units will vest on the 1st anniversary of the grant date and will be automatically settled in shares of common stock.
More from LIFECORE BIOMEDICAL, INC. \DE\
Regulatory Filings
2026
Jun 5
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Director's Dealing
2026
Mar 3
Board/Management Information
2026
Jan 16
Investor Presentation
2025
Nov 17
Interim / Quarterly Report
2025
Nov 6
Earnings Release
2025
Nov 6
Declaration of Voting Results & Voting Rights Announcements
2025
Oct 31
Major Shareholding Notification
2025
Oct 17